Miami Breast Institute is one of the first women’s centers in Florida to offer tomosynthesis for breast cancer screening. Breast tomosynthesis helps radiologists identify and characterize individual breast structures without the confusion of overlapping tissue.
MBI’s Selenia® Dimensions® breast tomosynthesis system is made by Hologic, a world leader in digital mammography. The Selenia Dimensions system offers exceptionally sharp breast images, an advanced ergonomic design providing more patient comfort, and the ground-breaking tomosynthesis platform designed to deliver superior screening and diagnostic performance.
Breast cancer screening with tomosynthesis when combined with a conventional 2D mammography has a higher cancer detection rate than conventional 2D mammography alone. Tomosynthesis technology gives radiologists increased confidence with a significant reduction in recall rates.
By offering women the latest technology in mammography, Miami Breast Institute hopes to increase the number of area women who will be routinely screened. Breast cancer is the second leading cause of cancer death among women, exceeded only by lung cancer. Statistics indicate that one in eight women will develop breast cancer sometime in her lifetime. The stage at which breast cancer is detected influences a woman’s chance of survival. If detected early, the five-year survival rate is 98 percent.
Miami Breast Institute is committed to the fight against breast cancer. In offering breast tomosynthesis digital mammography, Miami Breast Institute provides the latest in imaging quality. If you would like to schedule a mammogram or have questions about this important breast health procedure, please contact Miami Breast Institute.